Latest Final Reports
Final Report
69 reports
All (69)
August 2018
Executive Summary: Return on Investment of Tuberculosis in Thailand: A Cost-Benefit Analysis
July 2018
Research Report: Economic Evaluation and Budget Impact of Fludarabine – Cyclophosphamide and Rituximab for the Treatment of B-cell Chronic Lymphocytic Leukemia
March 2018
Research Report: Recommendations for Emergency Medical Service for the elderly in Thailand
February 2018
Research Report: Synthesis Research for Economic Evaluation of Primary Care Cluster Policy
January 2018
Research Report: Economic Evaluation of Vinorelbine for Adjuvant Therapy in Non-small Cell Lung Cancer Stage II – IIIA in Thailand